Journal for ImmunoTherapy of Cancer (Nov 2023)
614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study
- Bhumsuk Keam,
- Chan-Young Ock,
- Do-Youn Oh,
- Seung-Tae Kim,
- Keun-Wook Lee,
- Sun Young Rha,
- Changhoon Yoo,
- John Park,
- Min Hwan Kim,
- Sehyun Kim,
- Dhanusha Sabanathan,
- Joon Oh Park,
- Napa Parinyanitikul,
- Kyu Pyo Kim,
- Jaebong Yoon,
- Hyelim Lim,
- Sangheon Lee,
- Wooick Jang
Affiliations
- Bhumsuk Keam
- Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea
- Chan-Young Ock
- 1Lunit Inc., Seoul, Republic of Korea
- Do-Youn Oh
- Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
- Seung-Tae Kim
- Aff210 grid.414964.a0000000106405613Samsung Medical Center Seoul South Korea
- Keun-Wook Lee
- 1Seoul National University Bundang Hosp, Seoul, Korea, Republic of
- Sun Young Rha
- Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea
- Changhoon Yoo
- 6Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
- John Park
- 1Macquarie University, Sydney, Australia
- Min Hwan Kim
- 3Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea
- Sehyun Kim
- 1Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
- Dhanusha Sabanathan
- 2Department of Clinical Medicine, Macquarie University, Sydney, NSW, Australia
- Joon Oh Park
- 3Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
- Napa Parinyanitikul
- 4Division of Medical Oncology, Chulalongkorn University and the King Chulalongkorn Memorial Hospital, Bangkok, Thailand
- Kyu Pyo Kim
- 6Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
- Jaebong Yoon
- 9Y-biologics Inc., Daejeon, Korea, Republic of Korea
- Hyelim Lim
- 9Y-biologics Inc., Daejeon, Korea, Republic of Korea
- Sangheon Lee
- 9Y-biologics Inc., Daejeon, Korea, Republic of Korea
- Wooick Jang
- 9Y-biologics Inc., Daejeon, Korea, Republic of Korea
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0614
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.